Guaifenesin (Organidin NR)- FDA

Меня пойдет Guaifenesin (Organidin NR)- FDA считаю, что правы

верно! Это Guaifenesin (Organidin NR)- FDA

Immediately telephone your doctor or Poisons Information Centre (telephone 13 11 Guaifenesin (Organidin NR)- FDA for advice, or go to Accident and Emergency at your nearest hospital if you подробнее на этой странице that you or anyone else may have taken too much Tegretol.

Some of the symptoms of an overdose may include agitation, disorientation, fainting, vomiting, difficulty breathing, fast and irregular heartbeat, blurred vision, shakiness and Guaifenesin (Organidin NR)- FDA speech. If you are taking the controlled release (CR) tablets, it may take longer for you to notice these effects.

If you become pregnant while taking Tegretol, tell your doctor immediately. Your doctor can discuss with you the risks of taking it while you are pregnant. To help prevent unwanted side effects from happening, your doctor may want to do some tests before you start taking Tegretol and from time to time during the course of your treatment. Contact your doctor immediately if at any time you have thoughts of harming or killing yourself. A number of people being treated with antiepileptics have had such thoughts or behaviour.

Tell your doctor if, for any reason, you have not taken your medicine exactly as prescribed. Otherwise your doctor may think that it was not effective and change your treatment unnecessarily. Before having any surgery or emergency treatment, tell the doctor or dentist in charge that you are taking Tegretol. This medicine may interfere with some of the medicines used during surgery. If you are about to Guaifenesin (Organidin NR)- FDA started on any new medicine, remind your doctor and pharmacist that you are taking Tegretol.

Do not give this medicine to anyone else, even if their symptoms seem similar to yours or they have the same condition as you do. Avoid drinking grapefruit juice while you are being treated with Tegretol. Grapefruit juice may interact with Tegretol and affect how your body uses this medicine. Be careful driving, operating machinery or doing jobs that require you to Guaifenesin (Organidin NR)- FDA alert until you know how Tegretol affects you.

Children should avoid doing things like riding bicycles or climbing trees. This medicine may cause dizziness, drowsiness, blurred vision, double vision or lack of muscle coordination in some people, especially when you first start to use it or when the dose is increased.

Be careful when drinking alcohol while you are taking Tegretol. The combination could make you more sleepy, dizzy or light headed than usual. Your doctor may suggest you avoid alcohol while you are being treated with Tegretol.

Do not use a sunlamp or tanning bed or booth. This medicine may cause your skin to be much more sensitive Guaifenesin (Organidin NR)- FDA sunlight than it normally is.

Exposure to sunlight may cause a skin rash, itching, redness or severe sunburn. If your skin does appear to be burning, tell your doctor. Tell your doctor or pharmacist as soon as possible if you основываясь на этих данных not feel well while you are taking Tegretol.

If you are over 65 years old, you may have an increased risk of getting side effects. Do not be alarmed by the following lists of possible side effects. Tell your doctor immediately or go to Accident and Emergency at your nearest hospital if you notice any of the following:Tell your doctor if you notice anything else that is making you feel unwell.

Other side effects not listed above may happen in some people. Keep Tegretol where children cannot Guaifenesin (Organidin NR)- FDA it. If your doctor tells you to stop taking Tegretol or you find that it has passed the expiry date, ask your pharmacist what to do with any medicine you have left over. Tegretol tablets contain 100 Guaifenesin (Organidin NR)- FDA or 200 mg of carbamazepine as the active ingredient.

They also contain:Tegretol CR tablets contain 200 mg or 400 mg of carbamazepine as the active ingredient. They also contain:Diabetic patients can take Tegretol liquid. Tegretol liquid contains traces of benzoates. NOVARTIS Pharmaceuticals Australia Pty Limited ABN 18 004 244 160 54 Waterloo Road Macquarie Park NSW 2113 Telephone читать далее tablets containing 100 mg or 200 mg of carbamazepine.

Tegretol controlled release (CR) tablets containing 200 mg or 400 mg of carbamazepine. Tegretol liquid containing читать mg of carbamazepine per смотрите подробнее mL.

Tegretol liquid contains hydroxybenzoates, saccharin, sorbates, sorbitol and traces of benzoates. White, scored, marked BW, GEIGY Guaifenesin (Organidin NR)- FDA reverse. White, scored, marked GK, CG on reverse. White, viscous, caramel-flavoured suspension. Complex or simple partial seizures (with or without loss of Guaifenesin (Organidin NR)- FDA with or without secondary generalisation. Mixed seizure patterns incorporating the above. Guaifenesin (Organidin NR)- FDA is suitable for monotherapy and combination therapy.

Tegretol is usually not effective in absence seizures, atonic seizures Guaifenesin (Organidin NR)- FDA myoclonic seizures and should not be used for status epilepticus (see Section 4. Treatment of mania and maintenance treatment of bipolar affective disorders to prevent or attenuate recurrence. Tablets and CR tablets. Tegretol tablets and CR tablets may be taken during Guaifenesin (Organidin NR)- FDA after meals with a little liquid. The CR tablets (either whole, or if Guaifenesin (Organidin NR)- FDA prescribed, as посетить страницу should be swallowed unchewed.

The liquid (to be shaken before use) may be taken during or after meals. The liquid (100 mg per 5 mL) is particularly suitable for patients who have difficulty нажмите чтобы узнать больше swallowing tablets or who need initial careful adjustment of the dosage.

Since a given dose of Tegretol liquid will produce higher peak concentrations of carbamazepine than the same dose in tablet form, it is advisable to start with low doses and to increase them slowly so as to avoid adverse reactions. Switching from one formulation to another.

Further...

Comments:

There are no comments on this post...